|
Jul 29
|
Summit Hotel Properties (INN) Q2 FFO and Revenues Top Estimates
|
|
Jul 29
|
Summit Hotel Properties: Q2 Earnings Snapshot
|
|
Jul 29
|
SUMMIT HOTEL PROPERTIES REPORTS SECOND QUARTER 2024 RESULTS
|
|
Jul 29
|
All You Need to Know About Summit Hotel Properties (INN) Rating Upgrade to Strong Buy
|
|
Jul 29
|
3 Top Dividend Stocks to Maximize Your Retirement Income
|
|
Jul 26
|
Innocan Pharma Submits Investigational New Animal Drug Application to FDA's Veterinary Center
|
|
Jul 25
|
SUMMIT HOTEL PROPERTIES DECLARES SECOND QUARTER 2024 DIVIDENDS
|
|
Jun 24
|
SUMMIT HOTEL PROPERTIES ANNOUNCES SECOND QUARTER 2024 EARNINGS RELEASE DATE
|
|
Jun 13
|
Should Value Investors Buy Summit Hotel Properties (INN) Stock?
|
|
Jun 11
|
Innocan Pharma Announces Successful Preliminary Safety Evaluation of LPT-CBD in Minipigs
|
|
May 21
|
FDA Has Granted Innocan Pharma a Meeting Date for LPT-CBD for Chronic Pain
|
|
May 9
|
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey
|
|
May 3
|
Summit Hotel Properties, Inc. (NYSE:INN) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Summit Hotel Properties Inc (INN) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
|
|
May 1
|
SUMMIT HOTEL PROPERTIES REPORTS FIRST QUARTER 2024 RESULTS
|
|
Apr 22
|
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain
|
|
Apr 1
|
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M
|
|
Mar 26
|
SUMMIT HOTEL PROPERTIES ANNOUNCES FIRST QUARTER 2024 EARNINGS RELEASE DATE
|
|
Mar 25
|
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.
|
|
Mar 15
|
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million
|